IndiaInfoline » Markets » DIVISLAB

Divis Laboratories Ltd - Share Price

DIVISLAB

Open

1,802.00

Prev. Close

1,801.50

Turnover (lac.)

9,668

Day's High

1,824.00

Day's Low

1,772.55

52 Week's High

1,825.00

52 Week's Low

1,428.05

Book Value

286

Face Value

2

Mkt Cap (Cr.)

47,356

P/E

36.72

EPS

48.56

Divi. Yield

0.9

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd428.6039.31102,811.50823.160.643,215.0198.33
Dr Reddys Laboratories Ltd2,890.8019.1048,053.031,365.100.693,435.30852.70
Divis Laboratories Ltd1,783.8536.7247,339.68352.830.901,403.92266.77
Cipla Ltd455.4515.5636,731.62737.380.663,230.08209.72
Biocon Ltd289.00116.5534,686.00106.100.17523.9059.29

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Divis Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies. Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. The company has four ... More

Registered Office

1-72-23(P)/DIVIS/303 Divi Towe,Cyber Hills Gachibowli,Hyderabad, Telangana,500032

Tell. : +91-40-23786300/23786352/400
Website : http://www.divislaboratories.com
Email : mail@divislabs.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by divis-laboratories-ltd

View

- <

Reco. Price

Nov 15,2019 03:03 PM

Target Price

Target Returns:

0.00%

Result Express

Divis Laboratories Ltd's Q3FY19 standalone net profit rises 68.92% yoy to Rs379.49cr : In-line with Estimates

Dec 07, 2019 05:18 PM

The company’s standalone revenue stood at Rs1,342.92cr, up 29.39% yoy and 4.51% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    05 Nov 2019

    Annc. Date

    25 Oct 2019

    DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More

  • Purpose

    AGM

    Exp. Date

    23 Aug 2019

    Annc. Date

    25 Jul 2019

    AGM:23.08.2019Annual Report 2018-19 along with notice of Annual General Meeting and Intimation of Bo... More

  • Purpose

    Board Meeting

    Exp. Date

    23 Aug 2019

    Annc. Date

    23 Aug 2019

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201... More